A detailed history of Ubs Group Ag transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 459,669 shares of ASRT stock, worth $372,331. This represents 0.0% of its overall portfolio holdings.

Number of Shares
459,669
Previous 17,110 2586.55%
Holding current value
$372,331
Previous $20,000 1895.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.81 - $1.16 $358,472 - $513,368
442,559 Added 2586.55%
459,669 $399,000
Q3 2024

Nov 14, 2024

SELL
$1.07 - $1.75 $45,748 - $74,823
-42,756 Reduced 71.42%
17,110 $20,000
Q2 2024

Aug 13, 2024

SELL
$0.75 - $1.31 $32,505 - $56,776
-43,341 Reduced 41.99%
59,866 $74,000
Q1 2024

May 13, 2024

SELL
$0.79 - $1.14 $75,979 - $109,640
-96,176 Reduced 48.24%
103,207 $99,000
Q4 2023

Feb 09, 2024

SELL
$1.02 - $2.57 $44,951 - $113,259
-44,070 Reduced 18.1%
199,383 $213,000
Q3 2023

Nov 09, 2023

BUY
$2.52 - $5.69 $95,371 - $215,343
37,846 Added 18.41%
243,453 $623,000
Q2 2023

Aug 11, 2023

BUY
$5.0 - $7.66 $461,380 - $706,834
92,276 Added 81.42%
205,607 $1.11 Million
Q1 2023

May 12, 2023

BUY
$3.54 - $6.66 $341,422 - $642,337
96,447 Added 571.23%
113,331 $721,000
Q4 2022

Feb 08, 2023

BUY
$2.11 - $4.3 $18,897 - $38,510
8,956 Added 112.97%
16,884 $72,000
Q3 2022

Nov 10, 2022

BUY
$2.13 - $4.0 $7,005 - $13,156
3,289 Added 70.9%
7,928 $18,000
Q2 2022

Aug 10, 2022

BUY
$1.88 - $3.42 $7,497 - $13,638
3,988 Added 612.6%
4,639 $13,000
Q1 2022

May 16, 2022

BUY
$2.06 - $3.0 $49 - $72
24 Added 3.83%
651 $1,000
Q4 2021

Feb 14, 2022

SELL
$0.86 - $2.3 $1,935 - $5,175
-2,250 Reduced 78.21%
627 $1,000
Q3 2021

Nov 15, 2021

SELL
$0.89 - $1.55 $17,200 - $29,955
-19,326 Reduced 87.04%
2,877 $3,000
Q2 2021

Aug 13, 2021

BUY
$1.48 - $2.88 $32,860 - $63,944
22,203 New
22,203 $34,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $39M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.